Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses

被引：0
|
作者：
Christopher Pease
Brian Hutton
Fatemeh Yazdi
Dianna Wolfe
Candyce Hamel
Pauline Quach
Becky Skidmore
David Moher
Gonzalo G. Alvarez
机构：
[1] The Ottawa Hospital,Department of Medicine
[2] Ottawa Hospital Research Institute,undefined
[3] Ottawa University School of Epidemiology,undefined
[4] Public Health and Preventive Medicine,undefined
[5] Ottawa University Faculty of Medicine,undefined
来源：
BMC Infectious Diseases | / 17卷
关键词：
Systematic review; Network meta-analysis; Latent tuberculosis infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 12 条
  • [1] Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses
    Pease, Christopher
    Hutton, Brian
    Yazdi, Fatemeh
    Wolfe, Dianna
    Hamel, Candyce
    Quach, Pauline
    Skidmore, Becky
    Moher, David
    Alvarez, Gonzalo G.
    BMC INFECTIOUS DISEASES, 2017, 17
  • [2] A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection
    Pease, Christopher
    Hutton, Brian
    Yazdi, Fatemeh
    Wolfe, Dianna
    Hamel, Candyce
    Barbeau, Pauline
    Skidmore, Becky
    Alvarez, Gonzalo G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (06) : 557 - 566
  • [3] Hepatotoxicity, efficacy and completion rate between 3 months of isoniazid plus rifapentine and 9 months of isoniazid in treating latent tuberculosis infection: A systematic review and meta-analysis
    Tseng, Shao-Yu
    Huang, Yi-Shin
    Chang, Tien-En
    Perng, Chin-Lin
    Huang, Yi-Hsiang
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (11) : 993 - 1000
  • [4] Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
    Lai, Wendy A. A.
    Brethour, Kaitlyn
    D'Silva, Olivia
    Chaisson, Richard E. E.
    Zwerling, Alice A. A.
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [5] Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
    Wendy A. Lai
    Kaitlyn Brethour
    Olivia D’Silva
    Richard E. Chaisson
    Alice A. Zwerling
    BMC Public Health, 22
  • [6] Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials
    Assefa, Dawit Getachew
    Bedru, Ahmed
    Zeleke, Eden Dagnachew
    Negash, Solomon Emiru
    Debela, Dejene Tolossa
    Molla, Wondowsen
    Mengistu, Nebiyu
    Woldesenbet, Tigist Tekle
    Bedane, Neway Fekede
    Kajogoo, Violet Dismas
    Atim, Mary Gorret
    Manyazewal, Tsegahun
    ARCHIVES OF PUBLIC HEALTH, 2023, 81 (01)
  • [7] Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials
    Dawit Getachew Assefa
    Ahmed Bedru
    Eden Dagnachew Zeleke
    Solomon Emiru Negash
    Dejene Tolossa Debela
    Wondowsen Molla
    Nebiyu Mengistu
    Tigist Tekle Woldesenbet
    Neway Fekede Bedane
    Violet Dismas Kajogoo
    Mary Gorret Atim
    Tsegahun Manyazewal
    Archives of Public Health, 81
  • [8] Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
    McClintock, Adelaide H.
    Eastment, McKenna
    McKinney, Christy M.
    Pitney, Caroline L.
    Narita, Masahiro
    Park, David R.
    Dhanireddy, Shireesha
    Molnar, Alexandra
    BMC INFECTIOUS DISEASES, 2017, 17
  • [9] Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
    Adelaide H. McClintock
    McKenna Eastment
    Christy M. McKinney
    Caroline L. Pitney
    Masahiro Narita
    David R. Park
    Shireesha Dhanireddy
    Alexandra Molnar
    BMC Infectious Diseases, 17
  • [10] Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic review
    Pangprasertkul, Sipang
    Buawangpong, Nida
    Pinyopornpanish, Kanokporn
    Jiraporncharoen, Wichuda
    Angkurawaranon, Chaisiri
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
12